Dopaminergic mechanisms of target detection - P300 event related potential and striatal dopamine

Psychiatry Research - Neuroimaging

Volumn 194, Issue 3, 2011, Pages 212-218

  Pogarell, Oliver ^a   Padberg, Frank ^a   Karch, Susanne ^a   Segmiller, Felix ^a   Juckel, Georg ^b   Mulert, Christoph ^c   Hegerl, Ulrich ^d   Tatsch, Klaus ^a,e   Koch, Walter ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e Municipal Hospital of Karlsruhe Inc   (Germany)

Author keywords

Dopamine; IBZM; Oddball paradigm; P300; Single photon emission computed tomography (SPECT)

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; IOLOPRIDE I 123;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; ELECTROENCEPHALOGRAM; ELECTRONEUROLOGY; EVENT RELATED POTENTIAL; FEMALE; HUMAN; IN VIVO STUDY; MAJOR DEPRESSION; MALE; NUCLEAR MEDICINE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; BENZAMIDES; BRAIN MAPPING; CORPUS STRIATUM; DEPRESSIVE DISORDER, MAJOR; DOPAMINE; ELECTROENCEPHALOGRAPHY; EVENT-RELATED POTENTIALS, P300; FEMALE; HUMANS; IODINE ISOTOPES; MALE; MIDDLE AGED; PYRROLIDINES; STATISTICS, NONPARAMETRIC; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 82455212816     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2011.02.002     Document Type: Article

References (67)

1. Abi-Dargham A., Laruelle M., Seibyl J., Rattner Z., Baldwin R.M., Zoghbi S.S., Zea-Ponce Y., Bremner J.D., Hyde T.M., Charney D.S., Hoffer P.B., Innis R.B. SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: kinetic and equilibrium paradigms. Journal of Nuclear Medicine 1994, 35:228-238.
2. Abi-Dargham A., Gil R., Krystal J., Baldwin R.M., Seibyl J.P., Bowers M., van Dyck C.H., Charney D.S., Innis R.B., Laruelle M. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. The American Journal of Psychiatry 1998, 155:761-767.
3. Berman S.M., Noble E.P., Antolin T., Sheen C., Conner B.T., Ritchie T. P300 development during adolescence: effects of DRD2 genotype. Clinical Neurophysiology 2006, 117:649-659.
4. Carson R.E., Channing M.A., Blasberg R.G., Dunn B.B., Cohen R.M., Rice K.C., Herscovitch P. Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography. Journal of Cerebral Blood Flow and Metabolism 1993, 13:24-42.
5. Chang L.T. A method for attenuation correction in radionuclide computed tomography. IEEE Transactions on Nuclear Science 1978, 25:638-642.
6. Cropley V.L., Fujita M., Innis R.B., Nathan P.J. Molecular imaging of the dopaminergic system and its association with human cognitive function. Biological Psychiatry 2006, 59:898-907.
7. Dierks T., Maurer K. P300 evoked by an auditory and a visual paradigm and a semantic task. Psychiatry Research 1989, 29:439-441.
8. Donchin E., Coles M. Is the P300 component a manifestation of context updating?. The Behavioral and Brain Sciences 1988, 11:357-374.
9. Duncan G.E., Sheitman B.B., Lieberman J.A. An integrated view of pathophysiological models of schizophrenia. Brain Research Reviews 1999, 29:250-264.
10. Ebert D., Feistel H., Loew T., Pirner A. Dopamine and depression-striatal dopamine D2 receptor SPECT before and after antidepressant therapy. Psychopharmacology (Berlin) 1996, 126:91-94.
11. Ford J.M., Pfefferbaum A., Roth W. P3 and schizophrenia. Annals of the New York Academy of Sciences 1992, 658:146-162.
12. Frodl T., Hampel H., Juckel G., Burger K., Padberg F., Engel R.R., Moller H.J., Hegerl U. Value of event-related P300 subcomponents in the clinical diagnosis of mild cognitive impairment and Alzheimer's Disease. Psychophysiology 2002, 39:175-181.
13. Frodl T., Meisenzahl E.M., Muller D., Holder J., Juckel G., Moller H.J., Hegerl U. P300 subcomponents and clinical symptoms in schizophrenia. International Journal of Psychophysiology 2002, 43:237-246.
14. Frodl-Bauch T., Bottlender R., Hegerl U. Neurochemical substrates and neuroanatomical generators of the event-related P300. Neuropsychobiology 1999, 40:86-94.
15. Gallinat J., Riedel M., Juckel G., Sokullu S., Frodl T., Moukhtieva R., Mavrogiorgou P., Nissle S., Muller N., Danker-Hopfe H., Hegerl U. P300 and symptom improvement in schizophrenia. Psychopharmacology (Berlin) 2001, 158:55-65.
16. Gallinat J., Mulert C., Bajbouj M., Herrmann W.M., Schunter J., Senkowski D., Moukhtieva R., Kronfeldt D., Winterer G. Frontal and temporal dysfunction of auditory stimulus processing in schizophrenia. Neuroimage 2002, 17:110-127.
17. Gangadhar B.N., Ancy J., Janakiramaiah N., Umapathy C. P300 amplitude in non-bipolar, melancholic depression. Journal of Affective Disorders 1993, 28:57-60.
18. Halgren E., Baudena P., Clarke J.M., Heit G., Liegeois C., Chauvel P., Musolino A. Intracerebral potentials to rare target and distractor auditory and visual stimuli. I. Superior temporal plane and parietal lobe. Electroencephalography and Clinical Neurophysiology 1995, 94:191-220.
19. Halgren E., Baudena P., Clarke J.M., Heit G., Marinkovic K., Devaux B., Vignal J.P., Biraben A. Intracerebral potentials to rare target and distractor auditory and visual stimuli. II. Medial, lateral and posterior temporal lobe. Electroencephalography and Clinical Neurophysiology 1995, 94:229-250.
20. Halgren E., Marinkovic K., Chauvel P. Generators of the late cognitive potentials in auditory and visual oddball tasks. Electroencephalography and Clinical Neurophysiology 1998, 106:156-164.
21. Hegerl U. Event-related potentials in psychiatry: a new perspective. Pharmacopsychiatry 1994, 27:47-48.
22. Hegerl U., Frodl-Bauch T. Dipole source analysis of P300 component of the auditory evoked potential: a methodological advance?. Psychiatry Research 1997, 74:109-118.
23. Hegerl U., Juckel G., Muller-Schubert A., Pietzcker A., Gaebel W. Schizophrenics with small P300: a subgroup with a neurodevelopmental disturbance and a high risk for tardive dyskinesia?. Acta Psychiatrica Scandinavica 1995, 91:120-125.
24. Johnson R. A triarchic model of P300 amplitude. Psychophysiology 1986, 23:367-384.
25. Juckel G., Muller-Schubert A., Gaebel W., Hegerl U. Residual symptoms and P300 in schizophrenic outpatients. Psychiatry Research 1996, 65:23-32.
26. Kahkonen S., Ahveninen J., Jaaskelainen I.P., Kaakkola S., Naatanen R., Huttunen J., Pekkonen E. Effects of haloperidol on selective attention: a combined whole-head MEG and high-resolution EEG study. Neuropsychopharmacology 2001, 25:498-504.
27. Kawasaki T., Tanaka S., Wang J., Hokama H., Hiramatsu K. Abnormalities of P300 cortical current density in unmedicated depressed patients revealed by LORETA analysis of event-related potentials. Psychiatry and Clinical Neurosciences 2004, 58:68-75.
28. Kayser J., Bruder G.E., Tenke C.E., Stewart J.E., Quitkin F.M. Event-related potentials (ERPs) to hemifield presentations of emotional stimuli: differences between depressed patients and healthy adults in P3 amplitude and asymmetry. International Journal of Psychophysiology 2000, 36:211-236.
29. Kemp A.H., Hopkinson P.J., Hermens D.F., Rowe D.L., Sumich A.L., Clark C.R., Drinkenburg W., Abdi N., Penrose R., McFarlane A., Boyce P., Gordon E., Williams L.M. Fronto-temporal alterations within the first 200ms during an attentional task distinguish major depression, non-clinical participants with depressed mood and healthy controls: a potential biomarker?. Human Brain Mapping 2009, 30:602-614.
30. Kemp A.H., Pe Benito L., Quintana D.S., Clark C.R., McFarlane A., Mayur P., Harris A., Boyce P., Williams L.M. Impact of depression heterogeneity on attention: an auditory oddball event related potential study. Journal of Affective Disorders 2010, 123:202-207.
31. Kiehl K.A., Laurens K.R., Duty T.L., Forster B.B., Liddle P.F. Neural sources involved in auditory target detection and novelty processing: an event-related fMRI study. Psychophysiology 2001, 38:133-142.
32. Koch W., Radau P.E., Hamann C., Tatsch K. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. Journal of Nuclear Medicine 2005, 46:1109-1118.
33. Kung H.F., Alavi A., Chang W., Kung M.P., Keyes J.W., Velchik M.G., Billings J., Pan S., Noto R., Rausch A., Reilley J. In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans. Journal of Nuclear Medicine 1990, 31:573-579.
34. Laruelle M. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. Journal of Cerebral Blood Flow and Metabolism 2000, 20:423-451.
35. Laruelle M., Abi-Dargham A. Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies. Journal of Psychopharmacology 1999, 13:358-371.
36. Laruelle M., Abi-Dargham A., al-Tikriti M.S., Baldwin R.M., Zea-Ponce Y., Zoghbi S.S., Charney D.S., Hoffer P.B., Innis R.B. SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in nonhuman primates: II. Equilibrium analysis of constant infusion experiments and correlation with in vitro parameters. Journal of Cerebral Blood Flow & Metabolism 1994, 14:453-465.
37. Laruelle M., Abi-Dargham A., van Dyck C.H., Rosenblatt W., Zea-Ponce Y., Zoghbi S.S., Baldwin R.M., Charney D.S., Hoffer P.B., Kung H.F., Innis R.B. SPECT imaging of striatal dopamine release after amphetamine challenge. Journal of Nuclear Medicine 1995, 36:1182-1190.
38. Laruelle M., Abi-Dargham A., van Dyck C.H., Gil R., D'Souza C.D., Erdos J., McCance E., Rosenblatt W., Fingado C., Zoghbi S.S., Baldwin R.M., Seibyl J.P., Krystal J.H., Charney D.S., Innis R.B. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:9235-9240.
39. Luthringer R., Rinaudo G., Toussaint M., Bailey P., Muller G., Muzet A., Macher J. Electroencephalographic characterization of brain dopaminergic stimulation by apomorphine in healthy volunteers. Neuropsychobiology 1999, 39:49-56.
40. Malhi G.S., Berk M. Does dopamine dysfunction drive depression?. Acta Psychiatrica Scandinavica.Supplementum 2007, 116-124.
41. Malhi G.S., Parker G.B., Greenwood J. Structural and functional models of depression: from sub-types to substrates. Acta Psychiatrica Scandinavica 2005, 111:94-105.
42. McCarthy G., Wood C.C. Intracranial recordings of endogenous ERPs in humans. Electroencephalography and Clinical Neurophysiology. Supplement 1987, 39:331-337.
43. McKetin R., Ward P.B., Catts S.V., Mattick R.P., Bell J.R. Changes in auditory selective attention and event-related potentials following oral administration of d-amphetamine in humans. Neuropsychopharmacology 1999, 21:380-390.
44. Meyer J.H., McNeely H.E., Sagrati S., Boovariwala A., Martin K., Verhoeff N.P., Wilson A.A., Houle S. Elevated putamen D(2) receptor binding potential in major depression with motor retardation: an [11C]raclopride positron emission tomography study. The American Journal of Psychiatry 2006, 163:1594-1602.
45. Mulert C., Jager L., Schmitt R., Bussfeld P., Pogarell O., Moller H.J., Juckel G., Hegerl U. Integration of fMRI and simultaneous EEG: towards a comprehensive understanding of localization and time-course of brain activity in target detection. Neuroimage 2004, 22:83-94.
46. Mulert C., Pogarell O., Juckel G., Rujescu D., Giegling I., Rupp D., Mavrogiorgou P., Bussfeld P., Gallinat J., Moller H.J., Hegerl U. The neural basis of the P300 potential. Focus on the time-course of the underlying cortical generators. European Archives of Psychiatry and Clinical Neurosciences 2004, 254:190-198.
47. Mulert C., Juckel G., Giegling I., Pogarell O., Leicht G., Karch S., Mavrogiorgou P., Moller H.J., Hegerl U., Rujescu D. A Ser9Gly polymorphism in the dopamine D3 receptor gene (DRD3) and event-related P300 potentials. Neuropsychopharmacology 2006, 31:1335-1344.
48. Neuhaus A.H., Luborzewski A., Rentzsch J., Brakemeier E.L., Opgen-Rhein C., Gallinat J., Bajbouj M. P300 is enhanced in responders to vagus nerve stimulation for treatment of major depressive disorder. Journal of Affective Disorders 2007, 100:123-128.
49. Nishimura N., Ogura C., Ohta I. Effects of the dopamine-related drug bromocriptine on event-related potentials and its relation to the law of initial value. Psychiatry and Clinical Neurosciences 1995, 49:79-86.
50. Noble E.P., Berman S.M., Ozkaragoz T.Z., Ritchie T. Prolonged P300 latency in children with the D2 dopamine receptor A1 allele. American Journal of Human Genetics 1994, 54:658-668.
51. Oranje B., Gispen-de Wied C.C., Westenberg H.G., Kemner C., Verbaten M.N., Kahn R.S. No effects of l-dopa and bromocriptine on psychophysiological parameters of human selective attention. Journal of Psychopharmacology 2006, 20:789-798.
52. Oranje B., Gispen-de Wied C.C., Westenberg H.G., Kemner C., Verbaten M.N., Kahn R.S. Haloperidol counteracts the ketamine-induced disruption of processing negativity, but not that of the P300 amplitude. The International Journal of Neuropsychopharmacology 2009, 12:823-832.
53. Pfefferbaum A., Wenegrat B.G., Ford J.M., Roth W.T., Kopell B.S. Clinical application of the P3 component of event-related potentials. II. Dementia, depression and schizophrenia. Electroencephalography and Clinical Neurophysiology 1984, 59:104-124.
54. Pfefferbaum A., Ford J.M., White P.M., Mathalon D. Event-related potentials in alcoholic men: P3 amplitude reflects family history but not alcohol consumption. Alcoholism, Clinical and Experimental Research 1991, 15:839-850.
55. Pogarell O., Koch W., Popperl G., Tatsch K., Jakob F., Zwanzger P., Mulert C., Rupprecht R., Moller H.J., Hegerl U., Padberg F. Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: preliminary results of a dynamic [123I] IBZM SPECT study. Journal of Psychiatric Research 2006, 40:307-314.
56. Polich J. P300 and Alzheimer's disease. Biomedicine & Pharmacotherapy 1989, 43:493-499.
57. Polich J., Pollock V.E., Bloom F.E. Meta-analysis of P300 amplitude from males at risk for alcoholism. Psychological Bulletin 1994, 115:55-73.
58. Santosh P.J., Malhotra S., Raghunathan M., Mehra Y.N. A study of P300 in melancholic depression-correlation with psychotic features. Biological Psychiatry 1994, 35:474-479.
59. Schmitt G.J., Frodl T., Dresel S., la Fougere C., Bottlender R., Koutsouleris N., Hahn K., Moller H.J., Meisenzahl E.M. Striatal dopamine transporter availability is associated with the productive psychotic state in first episode, drug-naive schizophrenic patients. European Archives of Psychiatry and Clinical Neurosciences 2006, 256:115-121.
60. Shelley A.M., Catts S.V., Ward P.B., Andrews S., Mitchell P., Michie P., McConaghy N. The effect of decreased catecholamine transmission on ERP indices of selective attention. Neuropsychopharmacology 1997, 16:202-210.
61. Sohn Y.H., Kim G.W., Huh K., Kim J.S. Dopaminergic influences on the P300 abnormality in Parkinson's disease. Journal of the Neurological Sciences 1998, 158:83-87.
62. Stanzione P., Fattapposta F., Giunti P., D'Alessio C., Tagliati M., Affricano C., Amabile G. P300 variations in Parkinsonian patients before and during dopaminergic monotherapy: a suggested dopamine component in P300. Electroencephalography and Clinical Neurophysiology 1991, 80:446-453.
63. Sutton S., Braren M., Zubin J., John E.R. Evoked-potential correlates of stimulus uncertainty. Science 1965, 150:1187-1188.
64. Takeshita S., Ogura C. Effect of the dopamine D2 antagonist sulpiride on event-related potentials and its relation to the law of initial value. International Journal of Psychophysiology 1994, 16:99-106.
65. Urretavizcaya M., Moreno I., Benlloch L., Cardoner N., Serrallonga J., Menchon J.M., Vallejo J. Auditory event-related potentials in 50 melancholic patients: increased N100, N200 and P300 latencies and diminished P300 amplitude. Journal of Affective Disorders 2003, 74:293-297.
66. Verleger R. Sequential effects on P3 in a counting task: a partial replication. Biological Psychology 1987, 25:221-246.
67. Verleger R. Event related potentials and cognition: a critique of the context updating hypothesis and an alternative interpretation of P3. The Behavioral and Brain Sciences 1988, 11:343-356.